@article{24375, keywords = {Anti-Infective Agents, Chagas disease, HIV Infections, Hepatitis B, Hepatitis B Surface Antigens, Humans, leprosy, Strongyloidiasis, Tuberculosis, United States}, author = {Bilodeau M and Burns S and Gawoski J and Moschella S and Ooi W}, title = {Co-morbid infections in Hansen's disease patients in the United States: considerations for treatment.}, abstract = {
120 patients attending a Hansen's disease public health satellite clinic were evaluated for selected latent co-morbidities, consisting of strongyloidiasis, Chagas disease, hepatitis B, HIV, and tuberculosis, and potential exacerbation by immunosuppressive therapy. Implications for treatment of Hansen's disease are discussed.
}, year = {2013}, journal = {The American journal of tropical medicine and hygiene}, volume = {89}, pages = {781-3}, month = {2013 Oct}, issn = {1476-1645}, doi = {10.4269/ajtmh.13-0167}, language = {eng}, }